Titre : Hémiplégie

Hémiplégie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hémiplégie : Questions médicales les plus fréquentes", "headline": "Hémiplégie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hémiplégie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-23", "dateModified": "2025-02-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hémiplégie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Paralysie", "url": "https://questionsmedicales.fr/mesh/D010243", "about": { "@type": "MedicalCondition", "name": "Paralysie", "code": { "@type": "MedicalCode", "code": "D010243", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636" } } }, "about": { "@type": "MedicalCondition", "name": "Hémiplégie", "alternateName": "Hemiplegia", "code": { "@type": "MedicalCode", "code": "D006429", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohamad A Mikati", "url": "https://questionsmedicales.fr/author/Mohamad%20A%20Mikati", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC. mohamad.mikati@dm.duke.edu." } }, { "@type": "Person", "name": "Lyndsey Prange", "url": "https://questionsmedicales.fr/author/Lyndsey%20Prange", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC." } }, { "@type": "Person", "name": "Julie Uchitel", "url": "https://questionsmedicales.fr/author/Julie%20Uchitel", "affiliation": { "@type": "Organization", "name": "From the Division of Pediatric Neurology, Duke University Health System, Duke University School of Medicine, Durham NC." } }, { "@type": "Person", "name": "April Boggs", "url": "https://questionsmedicales.fr/author/April%20Boggs", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA." } }, { "@type": "Person", "name": "Milton Pratt", "url": "https://questionsmedicales.fr/author/Milton%20Pratt", "affiliation": { "@type": "Organization", "name": "Division of Pediatric Neurology and Developmental Medicine, Duke University, Durham, NC, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36766763", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/cells12030420" } }, { "@type": "ScholarlyArticle", "name": "Reliability and validity of the Turkish version of general sleep disturbance scale (GSDS-T) in stroke.", "datePublished": "2023-01-26", "url": "https://questionsmedicales.fr/article/36701078", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s13760-023-02191-4" } }, { "@type": "ScholarlyArticle", "name": "Portuguese version of Bern Illegitimates Task Scale: adaptation and evidence of validity.", "datePublished": "2023-01-26", "url": "https://questionsmedicales.fr/article/36703229", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40359-023-01061-1" } }, { "@type": "ScholarlyArticle", "name": "Reliability of Mental Workload Index Assessed by EEG with Different Electrode Configurations and Signal Pre-Processing Pipelines.", "datePublished": "2023-01-26", "url": "https://questionsmedicales.fr/article/36772409", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/s23031367" } }, { "@type": "ScholarlyArticle", "name": "Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36761898", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2023.1082390" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Paralysie", "item": "https://questionsmedicales.fr/mesh/D010243" }, { "@type": "ListItem", "position": 6, "name": "Hémiplégie", "item": "https://questionsmedicales.fr/mesh/D006429" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hémiplégie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hémiplégie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hémiplégie", "description": "Comment diagnostique-t-on l'hémiplégie ?\nQuels tests sont utilisés pour évaluer l'hémiplégie ?\nL'électromyographie est-elle utile ?\nQuels signes cliniques indiquent l'hémiplégie ?\nL'hémiplégie peut-elle être confondue avec d'autres conditions ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hémiplégie", "description": "Quels sont les symptômes de l'hémiplégie ?\nL'hémiplégie affecte-t-elle la sensibilité ?\nPeut-on avoir des douleurs avec l'hémiplégie ?\nY a-t-il des troubles cognitifs associés ?\nL'hémiplégie peut-elle causer des problèmes émotionnels ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hémiplégie", "description": "Comment prévenir l'hémiplégie ?\nL'exercice régulier aide-t-il ?\nUne alimentation saine est-elle importante ?\nFaut-il éviter le tabac ?\nLe stress peut-il influencer le risque ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hémiplégie", "description": "Quels traitements sont disponibles pour l'hémiplégie ?\nLa physiothérapie est-elle efficace ?\nDes médicaments sont-ils prescrits ?\nLa chirurgie est-elle une option ?\nQuelles sont les approches complémentaires ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hémiplégie", "description": "Quelles complications peuvent survenir ?\nL'hémiplégie peut-elle entraîner des problèmes respiratoires ?\nY a-t-il un risque de thrombose ?\nDes troubles de la peau peuvent-ils se développer ?\nL'hémiplégie peut-elle affecter la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hémiplégie", "description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe mode de vie influence-t-il le risque ?\nLe stress est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006429?mesh_terms=Reproducibility+of+Results&page=999#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on l'hémiplégie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des imageries cérébrales comme l'IRM." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'hémiplégie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests neurologiques et des évaluations fonctionnelles sont utilisés pour mesurer la gravité." } }, { "@type": "Question", "name": "L'électromyographie est-elle utile ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à évaluer la fonction musculaire et la conduction nerveuse." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent l'hémiplégie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent une faiblesse unilatérale, des réflexes anormaux et des troubles de la coordination." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle être confondue avec d'autres conditions ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec d'autres troubles neurologiques comme l'hémiparésie." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'hémiplégie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une paralysie d'un côté, des troubles de la parole et des difficultés motrices." } }, { "@type": "Question", "name": "L'hémiplégie affecte-t-elle la sensibilité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des pertes de sensation ou des sensations anormales du côté affecté." } }, { "@type": "Question", "name": "Peut-on avoir des douleurs avec l'hémiplégie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs neuropathiques ou musculo-squelettiques peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des troubles cognitifs associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle causer des problèmes émotionnels ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes comme la dépression et l'anxiété sont fréquents après un AVC." } }, { "@type": "Question", "name": "Comment prévenir l'hémiplégie ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le contrôle des facteurs de risque comme l'hypertension et le diabète." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut réduire le risque d'accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "Une alimentation saine est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée aide à maintenir une bonne santé cardiovasculaire." } }, { "@type": "Question", "name": "Faut-il éviter le tabac ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque d'AVC et d'hémiplégie." } }, { "@type": "Question", "name": "Le stress peut-il influencer le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des problèmes de santé augmentant le risque d'AVC." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'hémiplégie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la rééducation physique, l'ergothérapie et des médicaments." } }, { "@type": "Question", "name": "La physiothérapie est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie aide à améliorer la mobilité et la force musculaire." } }, { "@type": "Question", "name": "Des médicaments sont-ils prescrits ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les anticoagulants ou les anti-inflammatoires peuvent être prescrits." } }, { "@type": "Question", "name": "La chirurgie est-elle une option ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être envisagée pour traiter des complications." } }, { "@type": "Question", "name": "Quelles sont les approches complémentaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme l'acupuncture ou la thérapie par le mouvement peuvent être bénéfiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des problèmes de déglutition et des contractures." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle entraîner des problèmes respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes respiratoires peuvent survenir en raison de la faiblesse musculaire." } }, { "@type": "Question", "name": "Y a-t-il un risque de thrombose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de thrombose veineuse profonde est accru chez les patients hémiplégiques." } }, { "@type": "Question", "name": "Des troubles de la peau peuvent-ils se développer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des escarres peuvent se former en raison d'une immobilité prolongée." } }, { "@type": "Question", "name": "L'hémiplégie peut-elle affecter la santé mentale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles mentaux comme la dépression sont fréquents après un AVC." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque d'hémiplégie augmente avec l'âge, surtout après 55 ans." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'AVC augmentent le risque d'hémiplégie." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des problèmes cardiovasculaires et d'AVC." } } ] } ] }

Sources (10000 au total)

Reliability and validity of the Turkish version of general sleep disturbance scale (GSDS-T) in stroke.

Stroke is a life-threatening condition with many complications. Sleep disturbances is one of them. Sleep disturbances effect quality of life, recovery and rehabilitation process. It is crucial to reve... After translation and culture validation of the scale was done, Pittsburgh Sleep Quality Index (PSQI) and the Turkish version of the GSDS was applied at admission and at 24 h to the 58 patients with s... Cronbach alpha coefficient of total score was found as 0.850 and test re-test reliability-related Cronbach alpha coefficient was 0.785.... GSDS-T is a reliable and valid tool to assess sleep disturbance in stroke patients....

Portuguese version of Bern Illegitimates Task Scale: adaptation and evidence of validity.

A new element for job stress called Illegitimate Tasks has been investigated in recent years, along with stress as an offense to self-theory. Illegitimate tasks are those that are either needless or u... This study aimed to adapt the Bern Illegitimate Tasks Scale to Portuguese and provide evidence of its validity, through a confirmatory factor analysis with a sample of 472 workers from different secto... The internal consistency, of the whole scale, measured by Cronbach's alpha, was 0.923 and 0.902 and 0.928 for the unnecessary tasks and, for unreasonable tasks subscales respectively. The confirmatory... The Portuguese version of the Bern Illegitimate Tasks Scale presents very good psychometric properties for the intended measurement goals and can now be used in research with Portuguese speaking sampl...

Reliability of Mental Workload Index Assessed by EEG with Different Electrode Configurations and Signal Pre-Processing Pipelines.

Mental workload (MWL) is a relevant construct involved in all cognitively demanding activities, and its assessment is an important goal in many research fields. This paper aims at evaluating the repro... Thirteen young healthy adults were enrolled and were asked to perform 45 min of Simon's task to elicit a cognitive demand. EEG data were collected using a 32-channel system with different electrode co... MWL assessed with different PPPs showed reliability ranging from good to very good in most of the electrode configurations (average consistency > 0.87 and average absolute agreement > 0.92). Larger fr... The most complex PPPs have been proven to ensure good reliability (>0.90) and sensitivity in all experimental conditions. In conclusion, we propose to use at least a two-electrode configuration (Fz an...

Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression.

Chronic viral hepatitis (CH) is a stage prior to cirrhosis and primary cancer. Standard protocols for CH assessment during the long follow-up period are of great importance for precise treatment and l... Total 503 lines of laboratory data from 2012 to 2021 were extracted from103 CHB patients who were followed-up in our hospital. They were divided into the remission group and the progression group acco... The models revealed that abundant serum alpha-fetoprotein (AFP) in the remission group was characteristically associated with hepatocyte destruction markers aspartate aminotransferase (AST) and alanin... This study clearly demonstrates the intrinsic quantitative relationship between serum AFP and liver aminotransferases involving antivirus treatment response. The model-based equation compensates for s...

Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary.

The chest-related electronic patient reported outcome (ePRO) diary was recently developed to assess chest-related symptoms experienced by pediatric and adolescent populations during upper respiratory ... This non-interventional, psychometric validation study involved participants (N = 195; n = 42 6-8 years; n = 47 9-11 years; n = 55 12-17 years, n = 51 18+ years) completing the chest-related ePRO diar... The measure demonstrated strong quality of completion and showed relatively similar trajectories of symptom scores over time within different age subgroups and good item response distribution properti... The findings demonstrate that the chest-related ePRO diary provides a valid, reliable, responsive measure of chest congestion symptoms experienced with the common cold in pediatric and adolescent popu...

Development of Capillary Zone Electrophoresis Method for the Simultaneous Separation and Quantification of Metformin and Pioglitazone in Dosage Forms; and Comparison with HPLC Method.

A capillary zone electrophoretic (CZE) method was developed, validated, and applied for the assay of metformin (MET) and pioglitazone (PIO) in pharmaceutical formulations. The optimum running buffer c...

Mixed methods instrument validation: Evaluation procedures for practitioners developed from the validation of the Swiss Instrument for Evaluating Interprofessional Collaboration.

Quantitative and qualitative procedures are necessary components of instrument development and assessment. However, validation studies conventionally emphasise quantitative assessments while neglectin... We employ a convergent parallel mixed methods design to analyse quantitative and qualitative questionnaire data. Data were collected from staff, supervisors, and patients of a university hospital and ... Questionnaires from 435 staff, 133 supervisors, and 189 patients were collected. Analysis of congruence potentially provides explanations why respondents' comments are off topic. Convergence between q... Mixed methods provide alternative means of collecting construct validity evidence. Our suggested procedures can be easily applied on empirical data and allow the congruence, convergence, and credibili...

Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.

Myometrial invasion is a prognostic factor for lymph node metastases and decreased survival in non-endometrioid endometrial carcinoma patients. Herein, we explored the mode of myometrial invasion diag... This was a historical cohort study nationwide with 30 centers in China between January 2000 and December 2019. Clinical data, including age, histology, method of myometrial invasion evaluation (MRI, C... Among the 490 patients, 89.59% presented myometrial invasion. The methods reported for myometrial invasion assessment were IFS in 23.47%, IGE in 69.59%, MRI in 37.96%, and CT in 10.20% of cases. The h... In China, the assessment of myometrial invasion in non-endometrioid endometrial carcinoma is often performed via IGE, but the reliability is relatively low in contrast to IFS. In clinical practice, IF...